WHO ICTRP trial
To determine whether administration of almitrine bismesylate can ameliorate…
EUCTR2020-002567-57-GB · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-002567-57-GB |
|---|---|
| Public title | To determine whether administration of almitrine bismesylate can ameliorate hypoxaemia in Covid-19 and augment effectiveness of supplementary oxygen therapy and respiratory support. |
| Scientific title | To determine whether administration of almitrine bismesylate can ameliorate hypoxaemia in Covid-19 and augment effectiveness of supplementary oxygen therapy and respiratory support - Almitrine bismesylate in COVID-19 |
| Primary sponsor | University of Oxford / Clinical Trials and Research Governance |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Covid-19 MedDRA version: 21.1 Level: PT Classification code 10001053 Term: Acute respiratory failure System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases… |
| Interventions | Product Name: Almitrine Bimesylate Pharmaceutical Form: Capsule INN or Proposed INN: Almitrine Bismesylate CAS Number: 29608-49-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50- Pharmaceutical form of… |
| Registration date | Oct 22, 2020 |
| Target size | 112 |
| Secondary IDs | 1.0 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: